Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity & Safety of Priorix-Tetra with New Working Seeds
NCT00892775Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2009
- Primary completion
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of GSK208136 in measles, mumps, rubella, varicella (VZV), sponsored by GSK. Started Jun 2009; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00892775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892775.